Gerben Ferwerda

7.2k total citations · 1 hit paper
85 papers, 4.9k citations indexed

About

Gerben Ferwerda is a scholar working on Epidemiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerben Ferwerda has authored 85 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Epidemiology, 36 papers in Immunology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerben Ferwerda's work include Respiratory viral infections research (35 papers), Pneumonia and Respiratory Infections (25 papers) and Immune Response and Inflammation (21 papers). Gerben Ferwerda is often cited by papers focused on Respiratory viral infections research (35 papers), Pneumonia and Respiratory Infections (25 papers) and Immune Response and Inflammation (21 papers). Gerben Ferwerda collaborates with scholars based in Netherlands, United States and United Kingdom. Gerben Ferwerda's co-authors include Mihai G. Netea, Bart Jan Kullberg, Stephen E. Girardin, Gosse J. Adema, Dirk J. de Jong, Jos W.M. van der Meer, Charles A. Dinarello, Marien I. de Jonge, Friederike Meyer‐Wentrup and J.W.M. van der Meer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Gerben Ferwerda

82 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages

2008 660 citations Mihai G. Netea, Gerben Ferwerda et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerben Ferwerda Netherlands	30	2.3k	1.7k	1.3k	1.2k	478	85	4.9k
Trude Helen Flo Norway	30	2.5k 1.1×	1.3k 0.8×	1.4k 1.0×	786 0.7×	374 0.8×	59	5.4k
Arnaud M. Didierlaurent Switzerland	37	3.5k 1.5×	1.8k 1.1×	1.5k 1.1×	1.7k 1.4×	237 0.5×	80	6.1k
Theo S. Plantinga Netherlands	36	1.9k 0.8×	1.7k 1.0×	1.2k 0.9×	1.2k 1.0×	235 0.5×	92	4.4k
Rachel M. McLoughlin Ireland	38	2.4k 1.1×	964 0.6×	1.7k 1.3×	1.2k 1.0×	447 0.9×	90	5.6k
Stephan R. Krutzik United States	29	2.8k 1.2×	1.4k 0.8×	966 0.7×	1.4k 1.1×	446 0.9×	41	5.5k
Shawn Skerrett United States	44	2.0k 0.9×	1.6k 0.9×	1.5k 1.1×	670 0.6×	419 0.9×	95	5.5k
Judd E. Shellito United States	36	3.0k 1.3×	2.2k 1.3×	1.1k 0.8×	1.4k 1.2×	267 0.6×	113	6.3k
Salomé LeibundGut‐Landmann Switzerland	38	3.4k 1.5×	1.6k 1.0×	1.2k 0.9×	1.5k 1.3×	278 0.6×	81	5.9k
Stefan Hippenstiel Germany	52	2.6k 1.1×	1.8k 1.1×	2.7k 2.0×	839 0.7×	483 1.0×	159	7.4k
Mustapha Si‐Tahar France	41	3.8k 1.7×	1.6k 1.0×	1.3k 1.0×	810 0.7×	322 0.7×	118	6.5k

Countries citing papers authored by Gerben Ferwerda

Since Specialization

Citations

This map shows the geographic impact of Gerben Ferwerda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerben Ferwerda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerben Ferwerda more than expected).

Fields of papers citing papers by Gerben Ferwerda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerben Ferwerda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerben Ferwerda. The network helps show where Gerben Ferwerda may publish in the future.

Co-authorship network of co-authors of Gerben Ferwerda

This figure shows the co-authorship network connecting the top 25 collaborators of Gerben Ferwerda. A scholar is included among the top collaborators of Gerben Ferwerda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerben Ferwerda. Gerben Ferwerda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaiser, David A., Werner G. Purschke, Simone Sell, et al.. (2024). Ultrasensitive Detection of Chemokines in Clinical Samples with Graphene‐Based Field‐Effect Transistors. Advanced Materials. 36(52). e2407487–e2407487. 10 indexed citations

Kaiser, David A., Werner G. Purschke, Simone Sell, et al.. (2024). Ultrasensitive Detection of Chemokines in Clinical Samples with Graphene‐Based Field‐Effect Transistors (Adv. Mater. 52/2024). Advanced Materials. 36(52).

Benner, Marilen, Dorien Feyaerts, Esther Fasse, et al.. (2020). Clusters of Tolerogenic B Cells Feature in the Dynamic Immunological Landscape of the Pregnant Uterus. Cell Reports. 32(13). 108204–108204. 22 indexed citations

Erp, Elisabeth A. van, Willem Luytjes, Gerben Ferwerda, & Puck B. van Kasteren. (2019). Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease. Frontiers in Immunology. 10. 548–548. 186 indexed citations

Cremers, Amelieke J. H., Fredrick M. Mobegi, Christa E. van der Gaast‐de Jongh, et al.. (2018). The Contribution of Genetic Variation of Streptococcus pneumoniae to the Clinical Manifestation of Invasive Pneumococcal Disease. Clinical Infectious Diseases. 68(1). 61–69. 18 indexed citations

Koch, Rebecca M., Matthijs Kox, Gerben Ferwerda, et al.. (2018). Short-term repeated HRV-16 exposure results in an attenuated immune response in vivo in humans. PLoS ONE. 13(2). e0191937–e0191937. 3 indexed citations

Kullaya, Vesla, Quirijn de Mast, André van der Ven, et al.. (2017). Platelets Modulate Innate Immune Response Against Human Respiratory Syncytial Virus In Vitro. Viral Immunology. 30(8). 576–581. 13 indexed citations

Ahout, Inge M. L., Aldert Zomer, Helma van den Hurk, et al.. (2017). Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children. BMJ Open. 7(6). e014596–e014596. 11 indexed citations

Henriet, Stefanie, Wendy W. J. van de Sande, Mark J. Lee, et al.. (2016). Decreased Cell Wall Galactosaminogalactan in Aspergillus nidulans Mediates Dysregulated Inflammation in the Chronic Granulomatous Disease Host. Journal of Interferon & Cytokine Research. 36(8). 488–498. 14 indexed citations

10.

Ahout, Inge M. L., et al.. (2015). Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels. Clinical and Vaccine Immunology. 23(3). 243–245. 25 indexed citations

11.

Ahout, Inge M. L., Elles Simonetti, Christa E. van der Gaast‐de Jongh, et al.. (2015). Reduced Expression of HLA-DR on Monocytes During Severe Respiratory Syncytial Virus Infections. The Pediatric Infectious Disease Journal. 35(3). e89–e96. 28 indexed citations

12.

Cremers, Amelieke J. H., et al.. (2014). The role of ZmpC in the clinical manifestation of invasive pneumococcal disease. International Journal of Medical Microbiology. 304(8). 984–989. 9 indexed citations

13.

Cremers, Amelieke J. H., Ferry Hagen, Peter W. M. Hermans, Jacques F. Meis, & Gerben Ferwerda. (2014). Diagnostic value of serum pneumococcal DNA load during invasive pneumococcal infections. European Journal of Clinical Microbiology & Infectious Diseases. 33(7). 1119–1124. 10 indexed citations

14.

Cremers, Amelieke J. H., et al.. (2014). Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia. Vaccine. 32(31). 3989–3994. 14 indexed citations

15.

Dorst, Bieke Van, Amelieke J. H. Cremers, Karolien Jans, et al.. (2014). Integration of clinical point-of-care requirements in a DNA microarray genotyping test. Biosensors and Bioelectronics. 61. 605–611. 1 indexed citations

16.

Ahout, Inge M. L., Gerben Ferwerda, & Ronald de Groot. (2013). Influenza vaccination in kids, are you kidding me?. Journal of Infection. 68. S100–S107. 5 indexed citations

17.

Bouwens, Mark, Stan de Kleijn, Gerben Ferwerda, et al.. (2011). Low‐frequency electromagnetic fields do not alter responses of inflammatory genes and proteins in human monocytes and immune cell lines. Bioelectromagnetics. 33(3). 226–237. 16 indexed citations

18.

Gow, Neil A. R., Mihai G. Netea, Carol A. Munro, et al.. (2007). Immune Recognition ofCandida albicansβ‐glucan by Dectin‐1. The Journal of Infectious Diseases. 196(10). 1565–1571. 253 indexed citations

19.

Netea, Mihai G., et al.. (2006). Recognition of Fungal Pathogens by Toll-Like Receptors. Current Pharmaceutical Design. 12(32). 4195–4201. 113 indexed citations

20.

Netea, Mihai G., Gerben Ferwerda, Dirk J. de Jong, et al.. (2005). The Frameshift Mutation in Nod2 Results in Unresponsiveness Not Only to Nod2- but Also Nod1-activating Peptidoglycan Agonists. Journal of Biological Chemistry. 280(43). 35859–35867. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact